focus -WSS

focus

author：entertainment 2025-09-05 03:01:31 - browse：42

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for the last day here.

ASCO is more than half done. There is free coffee on the exhibit floor. One booth barista said their team had made 1,400 espressos in a day. Everyone’s perspective is alternating between two verses from Smashing Pumpkins, who are, lest you forget, a Chicago band. “Today is the greatest day I’ve ever known.” Also: “I’ll burn my eyes out before I get out.”

What if sometimes cancer doctors could give less medicine?

Are cancer drugs more likely to be cures? Or could they instead turn cancer into a chronic disease, in which medicines keep tumors in check but patients have to deal with their side effects, both physical and financial, for the rest of their lives.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： New lesbian bars spark hope amid disappearing LGBTQ+ spaces

hotspot

WSS

Investment in vaccine development is lagging, report finds

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Ukrainian soldiers say they owe lives to US

White House pharmacy plagued with problems, investigation finds

Merck, Johnson & Johnson CEOs will testify on high drug prices

Merck, Johnson & Johnson CEOs will testify on high drug prices

entertainment

focus

What if sometimes cancer doctors could give less medicine?

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Wildfire smoke exposes gaps in outdoor worker protections

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Walensky prepares to leave CDC — and Congress — behind

Venture capital firm's plans to take over Akron hospital face hurdles

Jerome Adams on the need for new antivirals for Covid

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

In Memoriam: Notable people who died in 2023

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Reconstructing family trees of blood cells may help predict disease

entertainment

Supreme Court strikes down Biden student loan forgiveness program

White House pharmacy plagued with problems, investigation finds

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

Here's how to stay safe from wildfire smoke amid reduced air quality

Biogen walks away from Aduhelm, years after polarizing approval

Zyn nicotine pouches become unlikely player in latest culture war

hotspot

leisure time

hotspot

knowledge